<![CDATA[8 Drugs Approved for Primary Care: Q1 2026]]>
In the first quarter of 2026, the US Food and Drug Administration (FDA) issued a series of regulatory decisions spanning endocrinology, dermatology, obesity management, rare diseases, and men’s health. These approvals reflect continued momentum in both …